EWM
TXG icon

Empirical Wealth Management’s 10x Genomics TXG Stock Holding History

Empirical Wealth Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.23M Sell
32,182
-2,992
-9% -$78.4K 0.02% 353
2026
Q1 		$747K Buy
35,174
+16,170
+85% +$323K 0.01% 420
2025
Q4 		$310K Buy
+19,004
New +$287K 0.01% 689

Other funds holding TXG

SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CG
Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return
FC
Financial Consulate Hunt Valley, Maryland $899M AUM 20.23% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return
BEI
Benjamin Edwards Inc Clayton, Missouri $11B AUM 18.22% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return

Empirical Wealth Management's TXG Position: Q2 2026 in Review

Empirical Wealth Management reduced its 10x Genomics (TXG) stake by 8.5% in Q2 2026, selling an estimated $78.4K and leaving 32,182 shares worth $1.23M. The position accounts for 0.02% of the portfolio, ranked #353.

Empirical Wealth Management first reported a position in TXG in Q4 2025 and has held it in 3 quarters since. 88 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Empirical Wealth Management held 32,182 shares of 10x Genomics worth $1.23M as of Q2 2026.
  • Empirical Wealth Management sold 2,992 10x Genomics shares in Q2 2026, an estimated $78.4K.
  • 10x Genomics made up 0.02% of Empirical Wealth Management's portfolio in Q2 2026, its #353 holding.
  • Empirical Wealth Management first reported a position in 10x Genomics in Q4 2025 and has held it in 3 quarters since.
  • 88 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Empirical Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.